Navigation Links
Apama Medical, A Shifamed Portfolio Company, Closes $3.2M Series A-1 Financing Round
Date:9/16/2013

CAMPBELL, Calif., Sept. 16, 2013 /PRNewswire/ -- Shifamed LLC, a medical technology incubator, announced today that Apama Medical, Inc., one of its privately held portfolio companies, has raised $3.2M in Series A-1 financing.

Broadview Ventures led the financing round and converted its initial investment to Series A-1 equity. Broadview is a Boston-based investment firm focused on accelerating the development of promising technology in cardiovascular and neurovascular disease through targeted investments in early stage ventures. 

"We are pleased to have the support of Broadview Ventures with its solid track record of successful investments," shared Amr Salahieh, Founder and Chairman of Shifamed. "In addition, we are grateful for the NSF SBIR Grant that helped fund our breakthrough technology. Apama Medical offers significant medical technology advancement to electrophysiology (EP) therapies and highlights Shifamed's commitment to improving medical procedures in large, proven markets."

Apama Medical, focused on the EP market, offers a vastly superior catheter-based solution for the fastest growing market segment, atrial fibrillation (AF) ablation, which is expected to reach $2.0B in 2017.

"Broadview has a long history of supporting promising medical technology," said Christopher H. Colecchi, Managing Director of Broadview Ventures. "Apama has developed a unique platform in the AF Ablation market. We are excited about continuing our relationship and optimistic about the long-term prospects."

About Shifamed

Shifamed LLC is a privately held medical technology incubator focused on developing new medical products from concept to commercial release. To learn more about Shifamed, please visit www.shifamed.com.

About Apama Medical

Apama Medical is a privately held medical device company formed by Shifamed LLC, a Silicon Valley based medical device incubator. Apama is focused on the rapidly growing electrophysiology (EP) market in which mapping and ablation are estimated to reach $2.0B in 2017. To learn more about Apama Medical, please visit www.apamamedical.com.

About Broadview Ventures

Broadview's mission is to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investments in and support of early stage ventures. To learn more about Broadview Ventures, please visit http://www.broadviewventures.org.

MEDIA CONTACT:
Katie Arnold
SPRIG Consulting LLC
(408) 805-0520
katie@sprigconsulting.com


'/>"/>
SOURCE Shifamed LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Apama Medical Announces Issuance Of Patent For Low Profile Electrodes For Use On Balloons
2. SurgiCount Medical, Inc. announces new 3-year agreement with Novation
3. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
4. Acutus Medical, Inc. bringt 21 Millionen $ für die Serie-B-Finanzierung auf
5. Acutus Medical, Inc. Raises $21 Million Toward its B-Series Financing
6. Astute Medical, Inc. patrocinerà il simposio informativo presso il meeting sulla nefrologia in terapia intensiva
7. Astute Medical, Inc., veranstaltet Symposium aus anlaß des Critical Care Nephrology Kongress
8. Astute Medical, Inc. va accueillir un symposium éducatif lors dune réunion dédiée à la réanimation néphrologique
9. Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.
10. Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference
11. Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017  CVS Pharmacy, the retail ... a new store design to enhance the retail ... food, health-focused products and expanded beauty selections paired ... customers discover new offerings. Together with its innovative ... of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens is honoured ... Trade, the UK’s most prestigious award for business success. The company has ... revenues and has grown by a total of 400% over the last six ...
(Date:4/21/2017)... ... April 21, 2017 , ... BrightStar Care Salt Lake City, a home ... of Utah (APCUT) and has appointed Rex Wheeler as its new Director of Business ... our agency and our ability to provide quality care to the community,” said Tammara ...
(Date:4/21/2017)... ... April 21, 2017 , ... Each year, everyone is ... day to clean, plant trees and look forward to a better future. However, supporting ... doing something outdoors. Indoor air quality can be two to five times more polluted ...
(Date:4/21/2017)... ... April 21, 2017 , ... A ... for older shoulder replacement patients; post-operative recovery just might be even better than ... patients presenting with osteoarthritis following surgery: 262 patients under 65 and 103 patients ...
(Date:4/21/2017)... NC (PRWEB) , ... April 21, 2017 , ... ... non-profit a $5 million grant over five years to help end the disability ... ambitious 15-year plan in cooperation with the Global Clubfoot Initiative to end disability ...
Breaking Medicine News(10 mins):